SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing heavy selling, with widespread community sentiment labeling it a "rugpull" and "scam" amidst a significant market downturn. Many investors are openly criticizing its founder, Charles Hoskinson, and questioning ADA's long-term viability, suggesting a rotation into AI stocks or other cryptocurrencies. While some contrarian investors view current lows as a deep buying opportunity, the dominant discourse reflects strong bearish sentiment across the broader crypto market.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to overwhelming positive Phase 3 data for its ovarian cancer drug, relacorilant, which demonstrated improved survival and is touted as a potential new standard of care. This breakthrough has fueled speculation of a significant short squeeze, with community discussion highlighting the drug's blockbuster potential across cancer types and anticipating an upcoming regulatory decision for relacorilant in Cushing's syndrome. The strong pipeline progress is shifting the narrative around CORT as a leader in cortisol modulation, extending beyond its existing market to address major unmet medical needs.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending following an acquisition offer from Kimberly-Clark, creating an arbitrage opportunity as its market price trades below the proposed deal value. The community is actively debating this valuation alongside persistent concerns around Tylenol-related litigation, which many dismiss as unsubstantiated, further influenced by recent significant insider buying.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is a focal point of intense community debate, with many users expressing frustration over recent price declines and fears of a 'Christmas dump' or 'rugpull' despite ongoing positive ETF inflows. While long-term holders emphasize patience and the asset's foundational utility for cross-border payments, others are actively predicting further significant drops and perceived market manipulation. The conversation is largely split between unwavering belief in a future surge and growing cynicism over its immediate prospects.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica (CLS) is trending due to widespread community belief in its crucial "picks-and-shovels" role within the escalating AI infrastructure and data center buildout. Despite experiencing recent market volatility, investors are actively discussing its strong fundamentals, significant growth potential, and strategic positioning to capitalize on persistent demand for high-bandwidth networking products. Bullish sentiment is fueled by expectations of continued performance as a key enabler in the AI era.

Direxion Shares ETF Trust - Direxion Daily GOOGL Bear 1X Shares

Direxion Daily GOOGL Bear 1X Shares

Direxion Daily GOOGL Bear 1X Shares (GGLS) is actively trending as investors hotly debate Alphabet's recent market movements and upcoming financial reports. The community is buzzing with discussions about whether GOOGL's rally is sustainable, leading many to consider GGLS for potential bearish positions or hedging strategies against a perceived overextension.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devon Energy is seeing increased attention following numerous analyst upgrades and a robust financial report, which included solid earnings and a notable long-term natural gas supply agreement. The community is keenly discussing the company's perceived undervaluation, its strategic focus on a strong balance sheet, and its emerging initiatives in addressing growing energy demand from sectors like AI.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is surging on highly anticipated positive clinical trial results from its TETON-2 study, demonstrating efficacy for Tyvaso in idiopathic pulmonary fibrosis, a significant market opportunity. This breakthrough is sparking widespread community excitement around the company's strengthened position in pulmonary disease and its innovative pipeline, including recent FDA clearance for its UKidney xenotransplantation study.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is generating significant buzz, driven by a recent upgrade to investment grade by Moodys, reinforcing its robust financial health and market leadership. The company's aggressive strategy of investing in logistics and expanding its fintech credit portfolio fuels strong revenue and user growth, but simultaneously sparks intense community debate about near-term margin pressures versus long-term market dominance.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is trending following a wave of bullish analyst upgrades and the growing market narrative around solar and energy storage's critical role in powering AI data centers. The community is actively discussing the company's strong virtual power plant strategy and consistent cash generation as key drivers. This momentum comes despite broader market volatility and seasonal concerns often associated with the residential solar sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DOLE - Scalped a bit, but bought long calls so I don&#39;t miss out.

StockTwits Web

Dole plc

 - Scalped a bit, but bought long calls so I don't miss out.